Skip Navigation
Search Menu
Find an Expert

 


George E. Bigelow, Ph.D.

Photo of Dr. George E. Bigelow, Ph.D.

Director, Behavioral Pharmacology Research Unit

Professor of Psychiatry and Behavioral Sciences

Expertise: Psychologist

Locations

Johns Hopkins Bayview Medical Center
Appointment Phone: 410-550-0035

4940 Eastern Avenue
Baltimore, MD 21224 map

Johns Hopkins Bayview Medical Center
Appointment Phone: 410-550-6337

5501 Hopkins Bayview Circle
Asthma and Allergy Center
Baltimore, MD 21224 map

Contact for Research Inquiries

Johns Hopkins Bayview Medical Campus
Baltimore, MD 21224 map
Phone: 410-550-0035
Fax: 410-550-0030

Email me

Background

Titles

  • Director, Behavioral Pharmacology Research Unit
  • Professor of Psychiatry and Behavioral Sciences

Education

Additional Training

University of Minnesota, Minneapolis, Minnesota, 1971, Psychopharmacology

Research & Publications

Research Summary

Clinical research on substance abuse and its treatment. Human laboratory clinical pharmacology research evaluates the abuse liability and the subjective, behavioral, and physiological effects of drugs of abuse and of medications being developed or evaluated as possible treatments for substance abuse.Outpatient clinical trials research evaluates pharmacological and psychosocial treatments (especially incentive-based contingency management procedures) for substance abuse, and predictors of treatment response. Director of postdoctoral research training program in the behavioral pharmacology of substance abuse.

Selected Publications

  1. Walsh, S.L., Sullivan, J.T., Preston, K.L., Garner, J.E., & Bigelow, G.E. (1996). The effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. Journal of Pharmacology and Experimental Therapeutics, 279, 524-538.
  2. Bigelow, G. E., & Walsh, S.L. (1998). Evaluation of potential pharmacotherapies: response to cocaine challenge in the human laboratory. In S. Higgins & J. Katz (Eds.). Cocaine Abuse Research: Pharmacology, Behavior, and Clinical Applications. (pp. 209-238 )
  3. Academic Press, CA. Bigelow, G.E. & Silverman, K. (1999). Theoretical and empirical foundations of contingency management treatments for drug abuse. In S.T. Higgins and K. Silverman (Eds.), Motivating Behavior Change Among Illicit-Drug Abusers (pp. 15-31).
  4. Washington, DC: American Psychological Association. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine. 2000 2;343(18):1290-7.
  5. Griffiths RR, Bigelow GE, Ator NA. (2003). Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence, 70 (3) Supplement 1 ,.S41-S54.
Is this you? Edit Profile